Home » Stocks » POAI

Predictive Oncology Inc. (POAI)

Stock Price: $0.740 USD 0.025 (3.53%)
Updated November 27, 1:00 PM EST - Market closed
After-hours: $0.730 -0.010 (-1.35%) Nov 27, 4:31 PM

Stock Price Chart

Key Info

Market Cap 13.08M
Revenue (ttm) 1.31M
Net Income (ttm) -28.67M
Shares Out 17.68M
EPS (ttm) -3.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $0.740
Previous Close $0.715
Change ($) 0.025
Change (%) 3.53%
Day's Open 0.725
Day's Range 0.710 - 0.770
Day's Volume 408,325
52-Week Range 0.630 - 5.300

More Stats

Market Cap 13.08M
Enterprise Value 18.16M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 17.68M
Float 15.30M
EPS (basic) -6.29
EPS (diluted) -3.42
FCF / Share -0.85
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 554,388
Short Ratio 1.11
Short % of Float 3.62%
Beta 1.75
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 10.02
PB Ratio 0.99
Revenue 1.31M
Operating Income -30.59M
Net Income -28.67M
Free Cash Flow -12.87M
Net Cash -5.08M
Net Cash / Share -0.29
Gross Margin 67.36%
Operating Margin -2,342.03%
Profit Margin -2,195.10%
FCF Margin -985.38%
ROA -24.15%
ROE -169.76%
ROIC 1,611.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-0.01%115.57%43.45%-30.24%-31.23%103.27%147.98%95.34%33454.51%-
Gross Profit0.881.000.510.270.350.570.280.060.04-
Operating Income-26.62-8.30-6.06-6.53-4.40-6.47-8.93-7.16-4.11-2.35
Net Income-19.39-10.09-6.00-6.53-4.79-6.83-9.41-7.42-4.49-1.35
Shares Outstanding2.871.280.640.
Earnings Per Share-6.86-7.87-9.40-23.10-308.60-572.50-1,160.00-2,063.02-3,375.84-2,063.02
Operating Cash Flow-8.73-5.29-4.46-4.38-7.49-3.37-3.86-1.18-1.78-0.82
Capital Expenditures-0.01-0.18-0.05-0.03-0.03-0.10-0.16---
Free Cash Flow-8.74-5.47-4.50-4.41-7.52-3.47-4.02-1.18-1.78-0.82
Cash & Equivalents0.150.661.682.154.860.
Total Debt5.531.63---0.940.281.171.691.07
Net Cash / Debt-5.37-0.981.682.154.86-0.92-0.18-1.16-1.56-1.06
Book Value11.230.052.690.924.11-5.52-3.22-3.30-2.70-2.19
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Predictive Oncology Inc.
Country United States
Employees 29
CEO Carl Schwartz

Stock Information

Ticker Symbol POAI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: POAI


Predictive Oncology provides various healthcare products and services primarily in the United States. The company operates in three segments: Domestic, International, and Helomics. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' exposure to infectious fluids collected during surgical and other patient procedures, as well as provides proprietary cleaning fluid and filters for use with STREAMWAY System. The company also provides data and artificial intelligence (AI) driven contract research organization (CRO) services for clinical and translational research; a range of multi-omics assays; and AI driven predictive models for the discovery of targeted therapies. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was founded in 2002 and is based in Eagan, Minnesota.